Showing results (1671-1680 of 3,400) with videos related to

Sort By:
Pageof 340
Eclinicalmedicine|August 23, 2026
Quality of life assessment in individuals with schizophrenia: a COSMIN-based systematic review of S-QoL41 and S-QoL18 incorporating neurobiological supportMasoud Rahmati, Marianne Foiselle, Sara Fernandes, et al.
Eclinicalmedicine|August 23, 2026
Bone marrow failure syndromes across the age spectrum: diagnostic and therapeutic principlesJibran Durrani, Emma M Groarke, Mikkael A Sekeres
Eclinicalmedicine|August 27, 2026
Clearance of Treponema pallidum from oral and anal sites after treatment of secondary syphilis: results from a multi-centre, prospective, cross-sectional studyJanet M Towns, Janath A Fernando, Rebecca Wigan, et al.
Eclinicalmedicine|August 26, 2026
Long term outcome following pulmonary TB or lower respiratory tract illness in children: a prospective South African studyShaakira Chaya, Leah Githinji, Nicola Marozva, et al.
Eclinicalmedicine|August 27, 2026
Nurse-led hospital violence intervention programme versus standard care in Wales: a cost-effectiveness analysisShainur Premji, Simon C Moore, Daniel Tod, et al.
Eclinicalmedicine|August 28, 2026
Safety of routine antimicrobial prophylaxis for surgery (SAPPHIRE): a prospective multi-centre cohort studyTom E F Abbott, Priyanthi Dias, Jai Vairale, et al.
Eclinicalmedicine|September 1, 2026
Integration of lipidomic and polygenic risk scores within contemporary clinical cardiovascular risk assessment pathways: a multi-cohort development and validation studyAleksandar Dakic, Jingqin Wu, Tingting Wang, et al.
Eclinicalmedicine|September 6, 2026
Circadian and behavioral timing in MASLD: a systematic review of human observational studiesArunkumar Subramanian, Raja Affendi Raja Ali, Gavin Stewart Dawe, et al.
Eclinicalmedicine|March 15, 2021
Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patientsColin Pawlowski, A J Venkatakrishnan, Christian Kirkup, et al.
Eclinicalmedicine|November 29, 2021
Efficacy and safety of MIL60 compared with bevacizumab in advanced or recurrent non-squamous non-small cell lung cancer: a phase 3 randomized, double-blind studyRui Wan, Xiaorong Dong, Qun Chen, et al.
Pageof 340